DCGI asks Wockhardt, Ranbaxy to explain lapses

Singapore: The Indian Drug Controller General of India (DCGI) has written a letter to the drug maker Wockhardt to explai...

September 2, 2013 | Monday | Regulatory
Dr. Reddy's launches generic psychiatric drug

Singapore: Dr. Reddy's Laboratories has launched drug for psychiatric conditions, Divalproex Sodium extended release tab...

August 23, 2013 | Friday | News
Strides gets tentative FDA nod for HIV generic

Singapore: FDA has granted tentative approval to India-based Strides Arcolab's HIV drug emtricitabine and tenofovir diso...

August 2, 2013 | Friday | Regulatory
GSK hit by more bribery allegations in China

Singapore: Days after a probe was initiated by the Chinese police into alleged 'economic crimes' committed by senior off...

July 8, 2013 | Monday | News
Ranbaxy launches generic of Pioglitazone in US

Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has launched authorized generic ...

August 20, 2012 | Monday | News
Abbott rejigs strategy, realigns India business

Singapore: After acquiring the formulations business of India's Piramal Healthcare in 2010, US drug major Abbott Laborat...

July 12, 2013 | Friday | News
Chinese medicine firm Tianyin gets GMP certificate

Singapore: China-based Tianyin Pharmaceutical (TPI) received GMP certification for its pre-extraction plant and formula...

September 16, 2013 | Monday | News
Natco wins patent dispute case against Teva

Singapore: Based in India's Hyderabad, drug manufacturing major Natco Pharmaceuticals has won a long standing patent dis...

March 4, 2014 | Tuesday | News
Lilly to expand generics manufacturing facility in China

Singapore: Lilly and Novast Laboratories have commenced the expansion of manufacturing and development facility capaciti...

March 6, 2014 | Thursday | News
Ranbaxy to market infliximab biosimilar

Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy La...

January 9, 2014 | Thursday | News
US FDA issues API bulk & tapped density guidance

Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...

July 11, 2013 | Thursday | Regulatory
Teva gets FDA nod for generics of Eli Lillys Evista

Singapore: Teva Pharmaceutical has recieved USFDA approval of the generic equivalent to Evista (Raloxifene) Tablets, 60 ...

March 5, 2014 | Wednesday | News
Sun Pharma revenue touches $480 million in Q2 2012

Mumbai: Sun Pharmaceutical Industries reported a growth of 62 percent in its net sales for the quarter ending June 30, 2...

August 10, 2012 | Friday | Company results
FIPB clears seven pharma proposals, defers three

Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...

July 8, 2013 | Monday | Regulatory
Australia temporarily bans 19 synthetic drugs

Singapore: The Australian government has imposed a temporary ban on sales of 19 synthetic drugs pursuant to the product ...

June 21, 2013 | Friday | Regulatory
Generics market to touch $231 bn by 2017: Report

Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to t...

June 4, 2012 | Monday | Analysis
Bayer to acquire China's OTC firm

Singapore: Bayer plans to acquire 100 percent of the shares of Dihon Pharmaceutical, a privately held pharmaceutical com...

February 28, 2014 | Friday | News
Actavis clocks $8.7 bn revenue in 2013

Singapore: Global pharmaceutical company Actavis has clocked net revenue of $8.7 billion in the year 2013, marking an in...

February 21, 2014 | Friday | Company results